A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus

NCT01991795 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

19271

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Ticagrelor 60 mg
DRUG: Ticagrelor placebo

Sponsor

AstraZeneca